FR3068366B1 - Procede de production de progeniteurs erythroides - Google Patents

Procede de production de progeniteurs erythroides Download PDF

Info

Publication number
FR3068366B1
FR3068366B1 FR1756222A FR1756222A FR3068366B1 FR 3068366 B1 FR3068366 B1 FR 3068366B1 FR 1756222 A FR1756222 A FR 1756222A FR 1756222 A FR1756222 A FR 1756222A FR 3068366 B1 FR3068366 B1 FR 3068366B1
Authority
FR
France
Prior art keywords
erythroid progenitors
producing erythroid
producing
bringing
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1756222A
Other languages
English (en)
Other versions
FR3068366A1 (fr
Inventor
Laurence Guyonneau-Harmand
Loic Garcon
Frédéric Aurade
Nicolas Rebergue
Frédéric Relaix
Luc Douay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Etablissement Francais du Sang
Sorbonne Universite
Original Assignee
Universite Pierre et Marie Curie
Institut National de la Sante et de la Recherche Medicale INSERM
Etablissement Francais du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1756222A priority Critical patent/FR3068366B1/fr
Application filed by Universite Pierre et Marie Curie, Institut National de la Sante et de la Recherche Medicale INSERM, Etablissement Francais du Sang filed Critical Universite Pierre et Marie Curie
Priority to JP2019572440A priority patent/JP7162625B2/ja
Priority to CN201880044213.0A priority patent/CN111373029B/zh
Priority to CA3067551A priority patent/CA3067551A1/fr
Priority to US16/627,396 priority patent/US20200370015A1/en
Priority to AU2018293389A priority patent/AU2018293389B2/en
Priority to PCT/EP2018/067833 priority patent/WO2019002625A1/fr
Priority to EP18733656.5A priority patent/EP3645707A1/fr
Priority to KR1020207002966A priority patent/KR102744512B1/ko
Publication of FR3068366A1 publication Critical patent/FR3068366A1/fr
Application granted granted Critical
Publication of FR3068366B1 publication Critical patent/FR3068366B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/45—Artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de production in vitro de progéniteurs érythroïdes comprenant la mise en contact de cellules souches hématopoïétiques, génétiquement modifiées ou non, avec un milieu de culture cellulaire défini comprenant une hormone glucocorticoïde et un inducteur d'autophagie.
FR1756222A 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides Active FR3068366B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR1756222A FR3068366B1 (fr) 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides
CN201880044213.0A CN111373029B (zh) 2017-06-30 2018-07-02 产生红系祖细胞的方法
CA3067551A CA3067551A1 (fr) 2017-06-30 2018-07-02 Procede de production de progeniteurs erythroides
US16/627,396 US20200370015A1 (en) 2017-06-30 2018-07-02 Method for producing erythroid progenitor cells
JP2019572440A JP7162625B2 (ja) 2017-06-30 2018-07-02 赤血球系前駆細胞を作製する方法
AU2018293389A AU2018293389B2 (en) 2017-06-30 2018-07-02 Method for producing erythroid progenitor cells
PCT/EP2018/067833 WO2019002625A1 (fr) 2017-06-30 2018-07-02 Procédé de production de progéniteurs érythroïdes
EP18733656.5A EP3645707A1 (fr) 2017-06-30 2018-07-02 Procédé de production de progéniteurs érythroïdes
KR1020207002966A KR102744512B1 (ko) 2017-06-30 2018-07-02 적혈구 전구체 세포의 생산 방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1756222 2017-06-30
FR1756222A FR3068366B1 (fr) 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides

Publications (2)

Publication Number Publication Date
FR3068366A1 FR3068366A1 (fr) 2019-01-04
FR3068366B1 true FR3068366B1 (fr) 2023-11-24

Family

ID=60450747

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1756222A Active FR3068366B1 (fr) 2017-06-30 2017-06-30 Procede de production de progeniteurs erythroides

Country Status (9)

Country Link
US (1) US20200370015A1 (fr)
EP (1) EP3645707A1 (fr)
JP (1) JP7162625B2 (fr)
KR (1) KR102744512B1 (fr)
CN (1) CN111373029B (fr)
AU (1) AU2018293389B2 (fr)
CA (1) CA3067551A1 (fr)
FR (1) FR3068366B1 (fr)
WO (1) WO2019002625A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7194030B2 (ja) * 2019-01-30 2022-12-21 株式会社エビデント 赤血球モニタリング装置
WO2022089606A1 (fr) * 2020-10-30 2022-05-05 Westlake Therapeutics (Hangzhou) Co. Limited Procédés de préparation de globules rouges matures in vitro
JPWO2023277153A1 (fr) * 2021-06-30 2023-01-05
WO2024010317A1 (fr) * 2022-07-04 2024-01-11 주식회사 아트블러드 Établissement d'une lignée cellulaire progénitrice érythroïde immortalisée ayant une capacité supérieure de différenciation en globules rouges par l'utilisation d'une combinaison de surexpression génétique, son procédé de préparation et son utilisation
CN119895031A (zh) * 2022-07-21 2025-04-25 法国血液机构 vitisin化合物用于生产造血细胞的用途
KR20240167593A (ko) * 2023-05-18 2024-11-27 주식회사 레드진 적혈구 생산용 형질전환 세포 및 이의 용도
CN116640728B (zh) * 2023-07-24 2023-10-20 呈诺再生医学科技(北京)有限公司 RO8191和AS2863619在诱导产生表达成人型β珠蛋白的脱核红细胞中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101441843B1 (ko) * 2005-10-18 2014-09-17 내셔날 쥬이쉬 헬스 조건부 불멸화 장기 줄기 세포 및 상기 세포의 제조 및 사용 방법
CA2628865A1 (fr) 2005-11-07 2007-05-18 The General Hospital Corporation Procedes et compositions de modulation du vieillissement des cellules souches
CN101045914A (zh) * 2006-03-29 2007-10-03 中国人民解放军军事医学科学院野战输血研究所 体外诱导造血干/祖细胞分化为成熟红细胞的方法与应用
ES2525411T3 (es) * 2008-07-21 2014-12-22 Taiga Biotechnologies, Inc. Células anucleadas diferenciadas y método para preparar las mismas
US20120252697A1 (en) 2009-09-01 2012-10-04 Mcmaster University Transformed human pluripotent stem cells and associated methods
CA2774193C (fr) * 2009-09-15 2020-08-25 The University Of Tokyo Nouveau procede de production de cellules differenciees
ES2608937T3 (es) * 2010-02-22 2017-04-17 Université Pierre Et Marie Curie (Paris 6) Medio de cultivo celular para el crecimiento y diferenciación de células del linaje hematopoyético
KR101930718B1 (ko) * 2012-03-28 2018-12-19 가부시키가이샤 쿠오리맨 앤 코. 불사화 줄기세포 및 그 생산물을 유효 성분으로 하는 의약 조성물 및 의약 제제
JP2016135100A (ja) * 2013-05-07 2016-07-28 学校法人金沢医科大学 赤芽球の脱核方法及び脱核赤血球の維持方法
WO2014186508A1 (fr) * 2013-05-15 2014-11-20 University Of Rechester Érythroblastes hautement auto-renouvelables (esre) humains
US11519901B2 (en) * 2015-04-03 2022-12-06 The University Of Tokyo Method for screening for cancer therapeutic agent
WO2017040945A1 (fr) * 2015-09-04 2017-03-09 Memorial Sloan Kettering Cancer Center Compositions à base de cellules immunitaires et leurs procédés d'utilisation

Also Published As

Publication number Publication date
JP7162625B2 (ja) 2022-10-28
EP3645707A1 (fr) 2020-05-06
KR102744512B1 (ko) 2024-12-19
CN111373029A (zh) 2020-07-03
AU2018293389A1 (en) 2020-01-16
JP2020525031A (ja) 2020-08-27
WO2019002625A1 (fr) 2019-01-03
KR20200060343A (ko) 2020-05-29
CN111373029B (zh) 2025-01-03
FR3068366A1 (fr) 2019-01-04
US20200370015A1 (en) 2020-11-26
CA3067551A1 (fr) 2019-01-03
AU2018293389B2 (en) 2024-10-10

Similar Documents

Publication Publication Date Title
FR3068366B1 (fr) Procede de production de progeniteurs erythroides
WO2021108717A3 (fr) Systèmes et procédés pour l'évaluation d'édition hors cible indépendante de cas9 d'acides nucléiques
MY199860A (en) Modified polypeptide with attenuated activity of citrate synthase and method for producing l-amino acid using the same
AU2017254264A1 (en) Method for producing retinal tissue
PH12020500115A1 (en) cAMP RECEPTOR PROTEIN VARIANT AND METHOD OF PRODUCING L-AMINO ACID USING THE SAME
WO2020081635A8 (fr) Nanocatalyseurs traités par la clairance rénale pour la surveillance d'une maladie
PH12020500113A1 (en) Camp receptor protein variant and method of producing l-amino acid using the same
MX2021001528A (es) Metodo para la produccion de celulas positivas para cd3.
JOP20210271A1 (ar) نظم زراعة الخلية واستخداماتها
UA92157C2 (ru) Способ продуцирования гормона роста
EA202190582A1 (ru) Способ получения энтеральных нейральных клеток-предшественников
FR3020379B1 (fr) Procede de production de methane par co-culture aerobie de microorganismes anaerobies
ZA202206307B (en) Methods for generating hematopoietic stem cells
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
BR112016023823A2 (pt) método para produção de um produto de fermentação
WO2019217493A3 (fr) Populations de cellules et expression génique associées à la différenciation de cellules bêta in vitro
MY202130A (en) Camp receptor protein variant and method of producing l-amino acid using the same
EP4389904A3 (fr) Micro-organismes pour la production de composés 4c-5c avec insaturation et procédés associés
CA3019753C (fr) Procede de culture cellulaire
ZA202107808B (en) Cell culture medium for eukaryotic cells
WO2020067618A8 (fr) MICRO-ORGANISME PRODUISANT UN ACIDE L-AMINÉ PRÉSENTANT UNE ACTIVITÉ α-GLUCOSIDASE AUGMENTÉE ET PROCÉDÉ DE PRODUCTION D'UN ACIDE L-AMINÉ L'UTILISANT
SG11201806843UA (en) Method for producing activated hepatocyte growth factor (hgf)
MX2022002121A (es) Produccion de cannabinoides.
MX2024003986A (es) Metodos para cuantificar el impacto de la tension de cizallamiento en lineas de celulas cho.
EP4512887A3 (fr) Procédés d'amélioration de la viabilité cellulaire dans un bioréacteur de production

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190104

PLFP Fee payment

Year of fee payment: 3

TQ Partial transmission of property

Owner name: ETABLISSEMENT FRANCAIS DU SANG, FR

Effective date: 20200313

Owner name: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA, FR

Effective date: 20200313

Owner name: SORBONNE UNIVERSITE, FR

Effective date: 20200313

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9